These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1382425)

  • 21. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
    Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
    Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors.
    Martin BL
    Biochem Pharmacol; 1998 Aug; 56(4):483-8. PubMed ID: 9763224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets.
    Santos MT; Moscardó A; Vallés J; Martínez M; Piñón M; Aznar J; Broekman MJ; Marcus AJ
    Circulation; 2000 Oct; 102(16):1924-30. PubMed ID: 11034940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover.
    Ozaki Y; Yatomi Y; Jinnai Y; Kume S
    Biochem Pharmacol; 1993 Aug; 46(3):395-403. PubMed ID: 8394081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
    Lyall RM; Zilberstein A; Gazit A; Gilon C; Levitzki A; Schlessinger J
    J Biol Chem; 1989 Aug; 264(24):14503-9. PubMed ID: 2788167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.
    Yura Y; Kusaka J; Kondo Y; Tsujimoto H; Yoshida H; Sato M
    Arch Virol; 1995; 140(7):1181-94. PubMed ID: 7544112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide).
    Pumiglia KM; Lau LF; Huang CK; Burroughs S; Feinstein MB
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):441-9. PubMed ID: 1530576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    Nakashima S; Koike T; Nozawa Y
    Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and transient translocation of PLC-gamma 1 to the cytoskeleton of thrombin-stimulated platelets. Evidence for a role of tyrosine kinases.
    Guinebault C; Payrastre B; Mauco G; Breton M; Plantavid M; Chap H
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):687-93. PubMed ID: 7981623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A; Paul AK; Shukla SD
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
    Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-mediated activation of human B lymphocytes in a nonphosphotyrosine-dependent manner.
    Roifman CM; Wang G
    J Immunol; 1992 Aug; 149(4):1179-84. PubMed ID: 1380035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
    Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
    FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serine/threonine kinases in signal transduction in response to thrombin in human platelets. Use of 17-hydroxywortmannin to discriminate signals.
    Clemetson KJ; Kocher M; von Tscharner V
    Adv Exp Med Biol; 1993; 344():119-28. PubMed ID: 8209781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
    Gillespie J; Dye JF; Schachter M; Guillou PJ
    Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal regulation of the IgE-dependent 1,2-diacylglycerol production by tyrosine kinase activation in a rat (RBL 2H3) mast-cell line.
    Lin P; Fung SJ; Li S; Chen T; Repetto B; Huang KS; Gilfillan AM
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):109-14. PubMed ID: 7513150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.